Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Page logo
Latest News

Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference

New Brunswick, NJ (January 18th, 2023) -- Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15th. Biljana Naumovic, Worldwide Vice President, Oncology and Peter Lebowitz, Global Therapeutic Head, Oncology will represent the Company in a virtual session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

  • Investor Contact:
    ra-jjcus-investorrel@its.jnj.com

    Media Contact:
    ra-rndus-mediarelati@its.jnj.com
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue